[¹⁸F]FDG positron emission tomography within two weeks of starting erlotinib therapy can predict response in non-small cell lung cancer patients.

by Mammar Hachemi, Olivier Couturier, Laurent Vervueren, Pacôme Fosse, Franck Lacœuille, Thierry Urban, José Hureaux
Published 2014-01-01

18F- FDG PET/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab

by Pacôme FOSSE, Marie-Joelle KAISER, Gauthier NAMUR, Dominique de Seny, Michel G. MALAISE, Roland HUSTINX
Published 2018-02-01

Dissociation between 2-[18F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, in...

by Charline Rinkin, Pacôme Fosse, Olivier Malaise, Nathalie Chapelier, Jil Horrion, Laurence Seidel, Adelin Albert, Roland Hustinx, Michel G. Malaise
Published 2021-08-01